Reproductive Medicine Center, Hefei, Anhui, P.R. China.
Division of Life Sciences and Medicine, Reproductive and Genetic Hospital, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
PLoS One. 2022 Aug 15;17(8):e0268328. doi: 10.1371/journal.pone.0268328. eCollection 2022.
Hydrosalpinx is a chronic inflammatory condition with high recurrence rate, and it is reported among female population having fallopian tubal factor infertility. Previously, we have reported that interventional ultrasound sclerotherapy improves endometrial receptivity and pregnancy rate with negligible adverse effects in patients suffering from hydrosalpinx. During present investigation, we have used next generation sequencing (NGS) to characterize the isomiR profiles from the endometrium of patients suffering from hydrosalpinx before and after interventional ultrasound sclerotherapy. Our results indicated that miRNA arm shift and switch remained unaffected when compared in patients before and after interventional ultrasound sclerotherapy. We observed that isomiRs with trimming at 3' and isomiRs with canonical sequences were lower in post-treatment than in pre-treatment group. Gene ontology (GO) annotation and KEGG pathway analysis revealed that the expression of mature mir-30 was significantly lower in the pre-treatment as compared to post treatment group while the expression of mir-30 isomiR was 4.26-fold higher in pre-treatment when compared with the post-treatment group. These different expression patterns of mir-30 mature miRNA and mir-30 isomiRs in two groups are affecting the physiological function of the endometrium. Our results suggested that differential isomiR distribution in hydrosalpinx patients before and after treatment plays an important role in hydrosalpinx incidence and can help in designing novel strategy for the treatment of hydrosalpinx in female population.
输卵管积水是一种慢性炎症性疾病,复发率高,据报道,在患有输卵管因素不孕症的女性人群中较为常见。此前,我们已经报道过,介入性超声硬化疗法可改善子宫内膜容受性和妊娠率,且对患有输卵管积水的患者几乎没有不良影响。在本次研究中,我们使用下一代测序(NGS)来描述接受介入性超声硬化疗法前后患有输卵管积水患者的子宫内膜中的异微小 RNA(miRNA)谱。我们的研究结果表明,与介入性超声硬化疗法前后的患者相比,miRNA 臂移位和切换没有受到影响。我们观察到,经过治疗后,3'端修剪的异微小 RNA 和具有典型序列的异微小 RNA 含量较低。基因本体(GO)注释和KEGG 通路分析显示,与治疗后相比,治疗前成熟 mir-30 的表达显著降低,而与治疗后相比,治疗前的 mir-30 异微小 RNA 表达水平高 4.26 倍。两组间 mir-30 成熟 miRNA 和 mir-30 异微小 RNA 的这些不同表达模式影响了子宫内膜的生理功能。我们的研究结果表明,治疗前后输卵管积水患者中异微小 RNA 的分布差异在输卵管积水的发生中起重要作用,并有助于设计针对女性输卵管积水的新治疗策略。